These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The effect of topical corticosteroids on the susceptibility of immune animals to reinoculation with Herpes simplex. Easterbrook M; Wilkie J; Coleman V; Dawson CR Invest Ophthalmol; 1973 Mar; 12(3):181-4. PubMed ID: 4348132 [No Abstract] [Full Text] [Related]
45. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)]. Colin J; Chastel C Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719 [TBL] [Abstract][Full Text] [Related]
46. Antiviral drugs in the treatment of corneal virus disease. Kaufman HE Am J Med Sci; 1966 Feb; 251(2):236-9. PubMed ID: 5324051 [No Abstract] [Full Text] [Related]
47. "Treatment-resistance" to idoxuridine in herpetic keratitis. Coleman VR; Tsu E; Jawetz E Proc Soc Exp Biol Med; 1968 Dec; 129(3):761-5. PubMed ID: 4302153 [No Abstract] [Full Text] [Related]
48. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Gordon YJ; Romanowski EG; Araullo-Cruz T Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711 [TBL] [Abstract][Full Text] [Related]
49. Ocular herpes simplex. Brown DC Invest Ophthalmol; 1971 Mar; 10(3):210-5. PubMed ID: 4323327 [No Abstract] [Full Text] [Related]
50. Medical treatment of herpes. Kaufman HE Isr J Med Sci; 1972; 8(8):1231-4. PubMed ID: 4630596 [No Abstract] [Full Text] [Related]
51. Antiviral effect of asparaginase and of Burkitt cell extracts in combination with other drugs. Thiry L; Cappel R Biomedicine; 1974 May; 20(3):198-204. PubMed ID: 4373093 [No Abstract] [Full Text] [Related]
52. [Studies on the cytotoxicity of a new anti-herpetic agent, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, on the rabbit cornea]. Naito T; Shiota H; Kanematsu S; Mimura Y; Ogawa T Nippon Ganka Gakkai Zasshi; 1988 Apr; 92(4):573-7. PubMed ID: 2841833 [No Abstract] [Full Text] [Related]
55. Light intensity on the photodynamic inactivation of herpes simplex keratitis. Stanley JA; Pinnolis M Am J Ophthalmol; 1976 Mar; 81(3):332-6. PubMed ID: 176890 [No Abstract] [Full Text] [Related]
56. [Herpetic diseases of the cornea and their treatment]. Fanta H Klin Monbl Augenheilkd; 1969 May; 154(5):617-27. PubMed ID: 4902032 [No Abstract] [Full Text] [Related]
57. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU]. Oshima K Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686 [No Abstract] [Full Text] [Related]
58. [On the treatment of dendritic keratitis with para-fluorophenylalanine]. Graupner K; Müller F Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1968; 174(3):231-5. PubMed ID: 5301622 [No Abstract] [Full Text] [Related]
59. New isothiazole derivatives. II. Cytotoxicity and antiviral activity in tissue cultures. Inglot AD; Machoń Z; Wolna E; Wilimowski M; Prandota J Arch Immunol Ther Exp (Warsz); 1973; 21(6):891-902. PubMed ID: 4361627 [No Abstract] [Full Text] [Related]
60. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Romanowski EG; Bartels SP; Gordon YJ Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]